HomeNews News Ajanta Pharma jumps 3% on amalgamation approval Ajanta Pharma jumps 3% on amalgamation approval

Read more interesting news from around the globe with Wealth Doctor App

Google Play
 
Ajanta Pharma jumps 3% on amalgamation approval

Ajanta Pharma jumps 3% on amalgamation approval

Monday, March 20, 2017, 3:19 PM
Ajanta Pharma gained 3.2% in Monday’s trade as the company’s board of directors approved amalgamation of Gabs Investments with itself. The company for FY 2016-17 has also approved payment of interim dividend at Rs 7 per share. Ajanta Pharma on the NSE is currently trading at Rs 1846 per share and is up by Rs 52 per share or 2.9%.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Love Beyond Death Get It now!
 

How about our new look!

 
Great!
Mm.. Ok
Bad
 

Please select a category

Please write your feedback and suggestions